Abstract
Due to increasing of TB cases around the world, the search for new drugs is rising. For viability of a new drug, its time of treatment must be shorter, must be active against resistant strains and/or multidrug resistant strains and must be active against latent strains. Thiosemicarbazones compounds showed previously excellent activity against M. tuberculosis H37Rv. Nanoencapsulation of th…